Assessing the validity of tuberculosis surveillance data in California.

PubWeight™: 1.13‹?› | Rank: Top 10%

🔗 View Article (PMC 1617097)

Published in BMC Public Health on August 25, 2006

Authors

Joan E Sprinson1, Elizabeth S Lawton, Travis C Porco, Jennifer M Flood, Janice L Westenhouse

Author Affiliations

1: TB Control Branch, Division of Communicable Disease Control, California Department of Health Services, 850 Marina Bay Parkway, Building P, 2nd floor, Richmond, CA 94804-6403, USA. jsprinso@dhs.ca.gov

Articles citing this

Using routinely reported tuberculosis genotyping and surveillance data to predict tuberculosis outbreaks. PLoS One (2012) 1.15

Epidemiology of urban tuberculosis in the United States, 2000-2007. Am J Public Health (2011) 1.12

Extrapulmonary tuberculosis, human immunodeficiency virus, and foreign birth in North Carolina, 1993 - 2006. BMC Public Health (2008) 1.07

Willingness to share personal health record data for care improvement and public health: a survey of experienced personal health record users. BMC Med Inform Decis Mak (2012) 1.04

Determinants of multidrug-resistant tuberculosis clusters, California, USA, 2004-2007. Emerg Infect Dis (2010) 0.91

The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. Lancet (2016) 0.90

Tuberculosis and HIV co-infection, California, USA, 1993–2008. Emerg Infect Dis (2013) 0.89

Innovative quality-assurance strategies for tuberculosis surveillance in the United States. Tuberc Res Treat (2012) 0.87

Monitoring data quality in syndromic surveillance: learnings from a resource limited setting. J Glob Infect Dis (2012) 0.86

Tuberculosis treatment managed by providers outside the Public Health Department: lessons for the Affordable Care Act. PLoS One (2014) 0.84

The US National Tuberculosis Surveillance System: A Descriptive Assessment of the Completeness and Consistency of Data Reported from 2008 to 2012. JMIR Public Health Surveill (2015) 0.80

Articles cited by this

[''R"--project for statistical computing]. Ugeskr Laeger (2008) 41.69

Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recomm Rep (2001) 17.65

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med (2003) 14.40

The emergence of drug-resistant tuberculosis in New York City. N Engl J Med (1993) 12.71

WHO's new Stop TB Strategy. Lancet (2006) 5.59

The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med (1994) 4.87

Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep (2005) 3.54

Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest (1997) 3.07

Essential components of a tuberculosis prevention and control program. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep (1995) 2.43

Surveillance of tuberculosis in Europe. Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting on tuberculosis cases. Eur Respir J (1996) 1.57

The need for epidemic intelligence. Public Health Rep (1996) 1.35

Articles by these authors

Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial. Lancet (2009) 3.17

Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Arch Ophthalmol (2010) 2.98

Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial. Lancet (2011) 2.20

The effect of expanded antiretroviral treatment strategies on the HIV epidemic among men who have sex with men in San Francisco. Clin Infect Dis (2011) 2.20

The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol (2013) 2.17

Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment. Invest Ophthalmol Vis Sci (2011) 2.14

Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma. JAMA (2008) 2.12

Multidrug resistance among persons with tuberculosis in California, 1994-2003. JAMA (2005) 1.88

Identifying postelimination trends for the introduction and transmissibility of measles in the United States. Am J Epidemiol (2014) 1.69

How reliable are tests for trachoma?--a latent class approach. Invest Ophthalmol Vis Sci (2011) 1.65

A rationale for continuing mass antibiotic distributions for trachoma. BMC Infect Dis (2007) 1.48

Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial. PLoS Med (2010) 1.37

Childhood mortality in a cohort treated with mass azithromycin for trachoma. Clin Infect Dis (2011) 1.36

When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries. PLoS Negl Trop Dis (2009) 1.36

Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates. J Infect Dis (2004) 1.34

Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial. PLoS Negl Trop Dis (2012) 1.33

An ecological study of tuberculosis transmission in California. Am J Public Health (2006) 1.29

Prospects for advancing tuberculosis control efforts through novel therapies. PLoS Med (2006) 1.27

Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial. Cornea (2012) 1.23

The epidemiological dynamics of infectious trachoma may facilitate elimination. Epidemics (2011) 1.23

Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma. Am J Trop Med Hyg (2010) 1.20

The fitness cost of antibiotic resistance in Streptococcus pneumoniae: insight from the field. PLoS One (2012) 1.15

Efficacy of latrine promotion on emergence of infection with ocular Chlamydia trachomatis after mass antibiotic treatment: a cluster-randomized trial. Int Health (2011) 1.14

Elimination and eradication of neglected tropical diseases with mass drug administrations: a survey of experts. PLoS Negl Trop Dis (2013) 1.13

Risk factors for intraoperative complications in resident-performed phacoemulsification surgery. Ophthalmology (2009) 1.12

Extensively drug-resistant tuberculosis: new strains, new challenges. Expert Rev Anti Infect Ther (2008) 1.06

When tuberculosis comes back: who develops recurrent tuberculosis in california? PLoS One (2011) 1.05

Epidemiology of ulcerative keratitis in Northern California. Arch Ophthalmol (2010) 1.04

Travel and implications for the elimination of trachoma in ethiopia. Ophthalmic Epidemiol (2010) 1.03

Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants. BMC Public Health (2006) 1.01

Seasonal effects in the elimination of trachoma. Am J Trop Med Hyg (2005) 1.00

Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery. Ophthalmology (2009) 1.00

Neuroprotective effect of intravitreal triamcinolone acetonide against photoreceptor apoptosis in a rabbit model of subretinal hemorrhage. Invest Ophthalmol Vis Sci (2008) 1.00

Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity. PLoS Negl Trop Dis (2013) 0.98

HIV-1 superinfection and viral diversity. AIDS (2004) 0.98

Mass antibiotics for trachoma and the Allee effect. Lancet Infect Dis (2005) 0.97

Slow resolution of clinically active trachoma following successful mass antibiotic treatments. Arch Ophthalmol (2011) 0.97

Pregnancy-related mortality in California: causes, characteristics, and improvement opportunities. Obstet Gynecol (2015) 0.97

Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distribution. PLoS Negl Trop Dis (2009) 0.95

The clinical differentiation of bacterial and fungal keratitis: a photographic survey. Invest Ophthalmol Vis Sci (2012) 0.95

Optic disk size variability between African, Asian, white, Hispanic, and Filipino Americans using Heidelberg retinal tomography. J Glaucoma (2009) 0.94

Bias due to secondary transmission in estimation of attributable risk from intervention trials. Epidemiology (2003) 0.93

Differences in iris thickness among African Americans, Caucasian Americans, Hispanic Americans, Chinese Americans, and Filipino-Americans. J Glaucoma (2013) 0.93

Association of lens vault with narrow angles among different ethnic groups. Curr Eye Res (2012) 0.92

Reliability of measurements performed by community-drawn anthropometrists from rural Ethiopia. PLoS One (2012) 0.92

Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions. Invest Ophthalmol Vis Sci (2012) 0.91

Antituberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994-2006. Clin Infect Dis (2012) 0.91

Effects of corneal cross-linking on contrast sensitivity, visual acuity, and corneal topography in patients with keratoconus. Cornea (2013) 0.90

Tuberculosis and HIV co-infection, California, USA, 1993–2008. Emerg Infect Dis (2013) 0.89

Relationship between foveal cone structure and clinical measures of visual function in patients with inherited retinal degenerations. Invest Ophthalmol Vis Sci (2013) 0.88

Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma. Clin Infect Dis (2011) 0.88

Impact of HIV on novel therapies for tuberculosis control. AIDS (2008) 0.87

Anterior segment optical coherence tomography as a screening tool for the assessment of the anterior segment angle. Ophthalmic Surg Lasers Imaging (2009) 0.87

The effect of procedure room temperature and humidity on LASIK outcomes. Ophthalmology (2013) 0.86

Risk factors for ocular chlamydia after three mass azithromycin distributions. PLoS Negl Trop Dis (2011) 0.86

Adverse events after mass azithromycin treatments for trachoma in Ethiopia. Am J Trop Med Hyg (2011) 0.86

A decrease in drug resistance levels of the HIV epidemic can be bad news. Bull Math Biol (2004) 0.85

A cluster-randomized controlled trial evaluating the effects of mass azithromycin treatment on growth and nutrition in Niger. Am J Trop Med Hyg (2012) 0.83

Ultrasound-enhanced penetration of topical riboflavin into the corneal stroma. Invest Ophthalmol Vis Sci (2013) 0.82

HIV drug-resistant strains as epidemiologic sentinels. Emerg Infect Dis (2006) 0.82

Acanthamoeba keratitis in South India: a longitudinal analysis of epidemics. Ophthalmic Epidemiol (2012) 0.82

Early resident-performed cataract surgery. Ophthalmology (2011) 0.82

Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry. Pediatrics (2007) 0.81

Seasonal trends of microbial keratitis in South India. Cornea (2012) 0.81

Optic disc parameters from optovue optical coherence tomography: comparison of manual versus automated disc rim determination. J Glaucoma (2012) 0.80

Latrine promotion for trachoma: assessment of mortality from a cluster-randomized trial in Ethiopia. Am J Trop Med Hyg (2011) 0.80

Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India. Ophthalmic Epidemiol (2013) 0.80

Scleral intraocular pressure measurement in cadaver eyes pre- and postkeratoprosthesis implantation. Invest Ophthalmol Vis Sci (2014) 0.80

Impact of mass azithromycin distribution on malaria parasitemia during the low-transmission season in Niger: a cluster-randomized trial. Am J Trop Med Hyg (2014) 0.80

Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial. Br J Ophthalmol (2012) 0.80

Incongruent HIV and tuberculosis co-dynamics in Kenya: interacting epidemics monitor each other. Epidemics (2008) 0.80

Dexamethasone intravitreal implant for pseudophakic cystoid macular edema in patients with diabetes. Ophthalmic Surg Lasers Imaging Retina (2015) 0.80

Diagnostic challenges of central nervous system tuberculosis. Emerg Infect Dis (2008) 0.80

EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA. Retina (2015) 0.79

The association between latrine use and trachoma: a secondary cohort analysis from a randomized clinical trial. Am J Trop Med Hyg (2013) 0.79

Ex-PRESS outcomes using mitomycin-C, Ologen alone, Ologen with 5-fluorouracil. Int Ophthalmol (2014) 0.78

Comparison of optic disc parameters measured by RTVue-100 FDOCT versus HRT-II. J Glaucoma (2012) 0.78

Adult mortality in a randomized trial of mass azithromycin for trachoma. JAMA Intern Med (2013) 0.78

Estimating community prevalence of ocular Chlamydia trachomatis infection using pooled polymerase chain reaction testing. Ophthalmic Epidemiol (2014) 0.77

Resident-performed phacoemulsification surgery in tamsulosin-treated patients. Arch Ophthalmol (2010) 0.77

The Effect of Cumulative Dissipated Energy on Changes in Intraocular Pressure After Uncomplicated Cataract Surgery by Phacoemulsification. J Glaucoma (2016) 0.77

A Comparison of Resident-performed Argon and Selective Laser Trabeculoplasty in Patients With Open-angle Glaucoma. J Glaucoma (2016) 0.77

Cost analysis of virtual-reality phacoemulsification simulation in ophthalmology training programs. J Cataract Refract Surg (2013) 0.76

INCREASING SLEEP DURATION IS ASSOCIATED WITH GEOGRAPHIC ATROPHY AND AGE-RELATED MACULAR DEGENERATION. Retina (2016) 0.76

Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study. Am J Ophthalmol (2013) 0.75

Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I. Invest Ophthalmol Vis Sci (2013) 0.75

Correction: Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models. PLoS Negl Trop Dis (2015) 0.75

Rifampin monoresistant tuberculosis and HIV comorbidity in California, 1993-2008: a retrospective cohort study. AIDS (2013) 0.75

Correction: The Distribution of Ocular Chlamydia Prevalence across Tanzanian Communities Where Trachoma Is Declining. PLoS Negl Trop Dis (2015) 0.75

Evaluation of fungal keratitis using a newly developed computer program, Optscore, for grading digital corneal photographs. Ophthalmic Epidemiol (2014) 0.75

Comparison of autophotomontage software programs in eyes with CMV retinitis. Invest Ophthalmol Vis Sci (2011) 0.75

Correction: Evaluating Subcriticality during the Ebola Epidemic in West Africa. PLoS One (2016) 0.75

In Reply. Obstet Gynecol (2019) 0.75

High prevalence of narrow angles among Filipino-American patients. J Glaucoma (2011) 0.75

Epidemiology of tuberculosis cases with end-stage renal disease, California, 2010. Am J Nephrol (2014) 0.75

Effect of timing and duration of tamsulosin exposure on complications in resident-performed phacoemulsification. Ophthalmic Surg Lasers Imaging (2011) 0.75

Annual Versus Biannual Mass Azithromycin Distribution and Malaria Parasitemia During the Peak Transmission Season Among Children in Niger. Pediatr Infect Dis J (2017) 0.75

Incidence of unplanned return to the operating room following vitreoretinal surgery at a public teaching hospital. Curr Eye Res (2013) 0.75

Distribution of behavioral patterns prior to infection among San Francisco men who have sex with men newly infected with HIV in 2014. J Acquir Immune Defic Syndr (2017) 0.75